Global Naloxone Market, by Strength (0.4 mg/ml, 1mg/ml, 0.4mg/0.4ml, and 4mg/0.1ml and Others), by Route of Administration (Intranasal, Intramuscular/Subcutaneous, and Intravenous), by Distribution Channel (Hospitals, Clinics, Retail Pharmacies, Online Pharmacies, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 310.2 Mn in 2017, and is projected to exhibit a CAGR of 11.4% over the forecast period (2018 – 2026).
Increasing launches of new
naloxone products in market is expected to be one of the major drivers fueling
the global naloxone market growth in the near future. For instance, in November
2015, Adapt Pharma Inc. received the U.S. Food and Drug Administration’s
(FDA’s) approval for its Narcan (naloxone HCl) nasal spray 4mg, indicated for
emergency treatment of known or suspected opioid overdose. In June 2016, Sandoz
Canada, a division of Novartis AG, launched S.O.S. naloxone hydrochloride
injection in Canada. In July 2017, Indivior Inc., a subsidiary of Indivior
Plc., received marketing authorization (MA) from the French Regulatory Agency,
French National Agency for Medicines and Health Products Safety (ANSM), for
Nalscue naloxone hydrochloride nasal spray, indicated for emergency treatment
of characterized or suspected opioid overdose, in France.
Browse 47 Market Data Tables and
33 Figures spread through 199 Pages and in-depth TOC on Naloxone Market, by
Strength (0.4 mg/ml, 1mg/ml, 0.4mg/0.4ml, and 4mg/0.1ml and Others), by Route
of Administration (Intranasal, Intramuscular/Subcutaneous, and Intravenous), by
Distribution Channel (Hospitals, Clinics, Retail Pharmacies, Online Pharmacies,
and Others), and Region (North America,
Latin America, Europe, Asia Pacific, the Middle East, and Africa) - Global
Forecast to 2026
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/1804
Increasing prevalence of opioid
overdosing in key countries such as the U.S. and Canada is expected to increase
demand for naloxone and significantly drive global naloxone market’s growth
over the forecast period. For instance, according to data published by Centers
for Disease Control and Prevention (CDC) in 2018, in the U.S. over 630,000
people died from a drug overdose from 1999 to 2016, and in 2016 around 66% of
the 63,600 drug overdose deaths involved an opioid. Furthermore, according to
the same source in 2016 the number of deaths involving opioids overdose (which
include prescription opioids, heroin, and fentanyl) was five times higher than
that in 1999. Favorable reimbursement scenarios for naloxone products is also
expected to boost the adoption of products and fuel the global naloxone market
growth. For instance, NARCAN nasal spray, a naloxone intranasal spray provided
by ADAPT Pharma Inc., has extensive public and private insurance coverage.
ADAPT Pharma Inc., entered into an agreement with major Pharmacy Benefits
Managers and insurance companies (including Medicaid) to ensure reasonable and
affordable costs to the patient. According to ADAPT Pharma Inc.’s official
website around 97% of the U.S. insured lives have access to NARCAN Nasal Spray
Furthermore, global naloxone market growth is also expected to rise due to the
collective initiatives by government and private organizations for increasing
accessibility of naloxone products for emergency treatment opioid overdose.
In 2017, 47 states and
Washington, DC in the U.S. expanded access to naloxone through legislation that
permits prescriptions to people who are likely to encounter someone who might
take drug overdose. In 2017, Ontario government provided naloxone kits to
police and fire departments to manage emergency case of opioid overdose.
Government offered naloxone kits to all 61 police services and 447 fire
departments in the Ontario.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/naloxone-market-1804
Key Takeaways of the Naloxone
Market:
The global naloxone market is
expected to exhibit a CAGR of 11.4% over the forecast period (2018 – 2026),
owing to frequent product launches, approval, and robust pipeline of novel
biopharmaceutical products
North America held the dominant
position in the global naloxone market and is expected to retain its dominance
over the forecast period (2018 – 2026). This is due to the high rates of opioid
overdose and due to presence of novel naloxone products such as Nacran nasal
spray in the region. For instance, in February, Adapt Pharma Inc., launched
Narcan nasal spray 4mg commercially in the U.S. market.
Europe is expected to witness
significant growth over the forecast period due to increasing launches of new
naloxone by key players in the region. For instance, in July 2017,, Indivior
Inc., a subsidiary of Indivior Plc., received marketing authorization (MA) from
the French Regulatory Agency ANSM for its new Nalscue naloxone hydrochloride
nasal spray, indicated for emergency treatment of characterized or suspected
opioid overdose, in France.
Furthermore, initiatives taken by
manufacturers with regulatory bodies to increase access for naloxone products
in case of emergency is also expected to have a positive impact on global
naloxone market’s growth. For instance, in 2017, 47 states and Washington, DC
in the U.S. have expanded access to naloxone through legislation that permits
prescriptions to people who are likely to encounter someone who might take drug
overdose.
Major players operating in the
Naloxone Market include Mylan N.V., Novartis AG, Indivior Plc., ADAPT Pharma,
Inc., Amphastar Pharmaceuticals, Inc., INSYS Therapeutics, Inc., Mundipharma
International Limited, Kaleo, Inc., and Kern Pharma, S.L.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/1804
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment